Altimmune Inc
ALT
Get informed when a big investor buys or sells
+ FollowMarket Cap$269.18M
Close$
$0.09
96.9% downside
Current Fair Value
96.9% downsideOvervalued by 96.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $269.18 Million |
|---|---|
| Enterprise Value | $207.43 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1 |
| Beta | 0.24 |
| Outstanding Shares | 124,461,818 |
Return
| Return on Equity | -32.07% |
|---|---|
| Return on Assets | -27.14% |
| Return on Invested Capital | -29.89% |
Valuation & Multiples
| P/E Ratio | -3.28 |
|---|---|
| PEG | -21.49 |
| Price to Sales | - |
| Price to Book Ratio | 1.47 |
| Enterprise Value to Revenue | 5761.97 |
| Enterprise Value to EBIT | -2.14 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$1,429
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.15
Average shareholder expectationRevenue Estimate
$1,750
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 64.29% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.47%▼ 78.27% |
|---|---|
| Total Invested | $1.78M▼ 99.17% |
| Investors Holding | 5▼ 178.00% |
ESG Score
No data
About Altimmune Inc
CEO: Vipin Garg